Edition:
India

Valeritas Holdings Inc (VLRX.OQ)

VLRX.OQ on NASDAQ Stock Exchange Capital Market

1.78USD
1:30am IST
Change (% chg)

$0.03 (+1.71%)
Prev Close
$1.75
Open
$1.82
Day's High
$1.82
Day's Low
$1.67
Volume
191,623
Avg. Vol
58,520
52-wk High
$7.30
52-wk Low
$1.20

Chart for

About

Valeritas Holdings, Inc. is a commercial-stage medical technology company. The Company is focused on developing technologies for Type 2 diabetes. The Company's product, the V-Go Wearable Insulin Delivery Device (V-Go), is an insulin delivery device that helps patients with Type 2 diabetes requiring insulin to maintain their... (more)

Overall

Beta: --
Market Cap(Mil.): $19.02
Shares Outstanding(Mil.): 6.84
Dividend: --
Yield (%): --

Financials

BRIEF-Valeritas Reports Q4 Loss Per Share ‍$3.10​

* VALERITAS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

27 Feb 2018

BRIEF-Valeritas Announces V-Go Distribution Agreement In Italy With Movi SpA

* VALERITAS ANNOUNCES V-GO® DISTRIBUTION AGREEMENT IN ITALY WITH MOVI SPA

22 Feb 2018

BRIEF-Valeritas Appoints Joseph Saldanha As Chief Business Officer

* VALERITAS APPOINTS JOSEPH SALDANHA AS CHIEF BUSINESS OFFICER Source text for Eikon: Further company coverage:

09 Jan 2018

BRIEF-Valeritas Sees Q4 Revenue About $5.6 Million

* SAYS EXPECTS FULL YEAR 2017 REVENUE TO REACH $20 MILLION, IN LINE WITH PRIOR GUIDANCE

08 Jan 2018

BRIEF-Valeritas Holdings Files For Sale Of Up To 3.35 Mln Shares

* VALERITAS HOLDINGS INC FILES FOR SALE OF UP TO 3.35 MILLION SHARES OF CO'S COMMON STOCK BY ASPIRE CAPITAL FUND LLC - SEC FILING Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

08 Jan 2018

BRIEF-Valeritas Holdings Enters Into Common Stock Purchase Agreement With Aspire Capital Fund

* VALERITAS HOLDINGS SAYS ON JAN 7, 2018, CO ENTERED INTO COMMON STOCK PURCHASE AGREEMENT WITH ASPIRE CAPITAL FUND - SEC FILING

08 Jan 2018

BRIEF-Valeritas Q3 revenue rises 4 pct

* Valeritas Holdings Inc - ‍gross margin increased to 39.8% during Q3 of 2017 as compared to 35.6% during same period in 2016​

09 Nov 2017

Earnings vs. Estimates